metricas

Acta Otorrinolaringológica Española

Sugerencias
Acta Otorrinolaringológica Española Guía de práctica clínica sobre el manejo del schwannoma vestibular
Información de la revista
Vol. 75. Núm. 2.
Páginas 73-136 (Marzo - Abril 2024)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
4421
Vol. 75. Núm. 2.
Páginas 73-136 (Marzo - Abril 2024)
ARTÍCULO ESPECIAL

Guía de práctica clínica sobre el manejo del schwannoma vestibular

Clinical practice guideline on the management of vestibular schwannoma
Visitas
4421
Luis Lassalettaa,b,c,
Autor para correspondencia
lassalettaluis@gmail.com

Autor para correspondencia.
, Leticia Acle Cerverad, Xabier Altunae, Emilio Amilibia Cabezaf, Miguel Arístegui Ruizg, Ángel Batuecas Caletrioh, Jesús Benítez del Rosarioi, Rubén Cabanillas Farpónj, María Costales Marcosk, Pedro Escadal, Juan Manuel Espinosa-Sánchezm, Roberto García Lealn, Javier Gavilána,b, Justo Gómez Martínezk, Rocío González-Aguadoo, Victor Martinez-Gonzalezp, Gloria Guerra Jiménezq, Alejandro Harguindey Antolí-Candelar, Borja J. Hernández Garcías, Cesar Orús Dotút..., Rubén Polo Lópezu, Manuel Manriquev, Eduardo Martín Sanzw, Roberto Martínez Álvarezx, Henry Martínezy,z, Marta Martínez-Martínezaa, Jorge Rey-Martineze, Francisco Ropero Romeroab, Santiago Santa Cruz Ruizh, Luis Ángel Vallejoac, Andrés Soto Varelaad, Isabel Varela-Nietob,c,ae, José Manuel Morales Pueblaa,b,cVer más
a Servicio de Otorrinolaringología, Hospital Universitario La Paz, Madrid, España
b Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, España
c Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, España
d Servicio de Otorrinolaringología, Hospital Infanta Leonor, Madrid, España
e Servicio de Otorrinolaringología, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
f Servicio de Otorrinolaringología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, España
g Servicio de Otorrinolaringología, Hospital Universitario Gregorio Marañón, Madrid, España
h Servicio de Otorrinolaringología, Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, España
i Servicio de Otorrinolaringología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Las Palmas, España
j Área de Medicina de Precisión, IMOMA, Oviedo, Asturias, España
k Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
l Servicio de Otorrinolaringología, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal
m Servicio de Otorrinolaringología, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, España
n Servicio de Neurocirugía, Hospital Universitario Gregorio Marañón, Madrid, España
o Servicio de Otorrinolaringología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España
p Center for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autónoma de Barcelona, Sabadell, Barcelona, España
q Servicio de Otorrinolaringología, Complejo Hospitalario Universitario Insular Materno Infantil de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, España
r Instituto de Otorrinolaringología IOM, Madrid, España
s Servicio de Neurocirugía, Hospital Universitario La Paz, Madrid, España
t Servicio de Otorrinolaringología, Hospital de la Santa Creu i Sant Pau, Barcelona, España
u Servicio de Otorrinolaringología, Hospital Universitario Ramón y Cajal, Madrid, España
v Servicio de Otorrinolaringología, Clínica Universitaria de Navarra, Pamplona, Navarra, España
w Servicio de Otorrinolaringología, Hospital Universitario de Getafe, Getafe, Madrid, España
x Servicio de Radiocirugía, Hospital Ruber Internacional, Madrid, España
y Servicio de Otorrinolaringología, Hospital Universitario Clínica San Rafael, Sur Bogotá D. C., Colombia
z Servicio de Otorrinolaringología, Hospital San José, Bogotá, Colombia
aa Servicio de Otorrinolaringología, Hospital Universitario San Cecilio, Granada, España
ab Servicio de Otorrinolaringología, Hospital Universitario Virgen Macarena, Sevilla, España
ac Servicio de Otorrinolaringología, Hospital Universitario Río Hortega, Valladolid, España
ad Servicio de Otorrinolaringología, Departamento de Cirugía y Especialidades Médico-Quirúrgicas, Complexo Hospitalario Universitario de Santiago, Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, A Coruña, España
ae Grupo de Audición y Mielinopatías, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, CIBERER-ISCIII, Madrid, España
Ver más
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Resumen
Introducción

El schwannoma vestibular (SV) es el tumor más frecuente del ángulo pontocerebeloso. La mayor accesibilidad a las pruebas radiológicas ha incrementado su diagnóstico. Teniendo en cuenta las características del tumor, la clínica y la edad del paciente se han propuesto tres estrategias terapéuticas, observación, cirugía o radioterapia. La elección de la más adecuada para cada paciente es un motivo de controversia frecuente.

Material y métodos

El presente trabajo incluye una revisión exhaustiva sobre cuestiones relativas al SV que pueden servir de guía clínica en el manejo de pacientes con estas lesiones. La presentación se ha orientado en forma de preguntas que el clínico se hace habitualmente y las respuestas están redactadas y/o revisadas por un panel de expertos nacionales e internacionales consultados por la Comisión de Otología de la SEORL-CCC.

Resultados

Se ha elaborado un listado con los 13 bloques temáticos más controvertidos sobre el manejo del SV en forma de 50 preguntas y se han buscado las respuestas a todas ellas mediante una revisión sistemática de la literatura (artículos publicados en PubMed y Cochrane Library entre 1992 y 2023 sobre cada bloque temático). Treinta y tres expertos, liderados por la Comisión de Otología de la SEORL-CCC, han analizado y discutido todas las respuestas. En el Anexo 1 pueden encontrarse 14 preguntas adicionales divididas en cuatro bloques temáticos.

Conclusiones

Esta guía de práctica clínica sobre el manejo del SV ofrece respuestas consensuadas a las preguntas más habituales que se plantean sobre este tumor. La ausencia de suficientes estudios prospectivos hace que los niveles de evidencia sobre el tema sean en general medios o bajos. Este hecho incrementa el interés de este tipo de guías de práctica clínica elaboradas por expertos.

Palabras clave:
Schwannoma vestibular
Neurinoma del acústico
Hipoacusia
Acúfeno
Resonancia nuclear magnética
Microcirugía
Radioterapia
Neurofibromatosis tipo 2
Abstract
Introduction

Vestibular schwannoma (VS) is the most common tumour of the cerebellopontine angle. The greater accessibility to radiological tests has increased its diagnosis. Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have been proposed: observation, surgery or radiotherapy. Choosing the most appropriate for each patient is a frequent source of controversy.

Material and methods

This paper includes an exhaustive literature review of issues related to VS that can serve as a clinical guide in the management of patients with these lesions. The presentation has been oriented in the form of questions that the clinician usually asks himself and the answers have been written and/or reviewed by a panel of national and international experts consulted by the Otology Commission of the SEORL-CCC.

Results

A list has been compiled containing the 13 most controversial thematic blocks on the management of VS in the form of 50 questions, and answers to all of them have been sought through a systematic literature review (articles published on PubMed and Cochrane Library between 1992 and 2023 related to each thematic area). Thirty-three experts, led by the Otology Committee of SEORL-CCC, have analyzed and discussed all the answers. In Annex 1, 14 additional questions divided into 4 thematic areas can be found.

Conclusions

This clinical practice guideline on the management of VS offers agreed answers to the most common questions that are asked about this tumour. The absence of sufficient prospective studies means that the levels of evidence on the subject are generally medium or low. This fact increases the interest of this type of clinical practice guidelines prepared by experts.

Keywords:
Vestibular schwannoma
Acoustic neuroma
Hearing loss
Tinnitus
Magnetic resonance imaging
Microsurgery
Radiotherapy
Neurofibromatosis type 2

Artículo

Opciones para acceder a los textos completos de la publicación Acta Otorrinolaringológica Española
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
J.P. Marinelli, C.M. Lohse, M.L. Carlson.
Incidence of vestibular schwannoma over the past half-century: A population-based study of Olmsted County, Minnesota.
Otolaryngol Head Neck Surg., 159 (2018), pp. 717-723
[2]
R. Goldbrunner, M. Weller, J. Regis, M. Lund-Johansen, P. Stavrinou, D. Reuss, et al.
EANO guideline on the diagnosis and treatment of vestibular schwannoma.
Neuro Oncol., 22 (2020), pp. 31-45
[3]
Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009). Oxford: CEBM, University of Oxford; 2020; [consultado 26 Jul 2023]. Disponible en: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
[4]
J.E. Xenellis, F.H. Linthicum Jr..
On the myth of the glial/schwann junction (Obersteiner-Redlich zone): Origin of vestibular nerve schwannomas.
[5]
C. Roosli, F.H. Linthicum Jr., S. Cureoglu, S.N. Merchant.
What is the site of origin of cochleovestibular schwannomas?.
Audiol Neurootol., 17 (2012), pp. 121-125
[6]
M.L. Carlson, M.J. Link.
Vestibular schwannomas.
N Engl J Med, 384 (2021), pp. 1335-1348
[7]
V.R. Kshettry, J.K. Hsieh, Q.T. Ostrom, C. Kruchko, J.S. Barnholtz-Sloan.
Incidence of vestibular schwannomas in the United States.
J Neurooncol., 124 (2015), pp. 223-228
[8]
M. De Vries, A.G. van der Mey, P.C. Hogendoorn.
Tumor biology of vestibular schwannoma: A review of experimental data on the determinants of tumor genesis and growth characteristics.
Otol Neurotol, 36 (2015), pp. 1128-1136
[9]
M.L. Carlson, J.B. Smadbeck, M.J. Link, E.W. Klee, G. Vasmatzis, L.A. Schimmenti.
Next generation sequencing of sporadic vestibular schwannoma: Necessity of biallelic NF2 inactivation and implications of accessory non-NF2 variants.
Otol Neurotol, 39 (2018), pp. e860-e871
[10]
D.G. Evans, A.J. Wallace, C. Hartley, S.R. Freeman, S.K. Lloyd, O. Thomas, et al.
Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene.
Laryngoscope., 129 (2019), pp. 967-973
[11]
A. Vienne-Jumeau, C. Tafani, D. Ricard.
Environmental risk factors of primary brain tumors: A review.
Rev Neurol (Paris)., 175 (2019), pp. 664-678
[12]
A. Bortkiewicz, E. Gadzicka, W. Szymczak.
Mobile phone use and risk for intracranial tumors and salivary gland tumors - A meta-analysis.
Int J Occup Med Environ Health., 30 (2017), pp. 27-43
[13]
M. Röösli, S. Lagorio, M.J. Schoemaker, J. Schüz, M. Feychting.
Brain and salivary gland tumors and mobile phone use: Evaluating the evidence from various epidemiological study designs.
Annu Rev Public Health., 40 (2019), pp. 221-238
[14]
K.A. Aaron, Z. Manojlovic, N. Tu, Y. Xu, Y. Jin, S. Chang, et al.
What genes can tell: A closer look at vestibular schwannoma.
Otol Neurotol., 41 (2020), pp. 522-529
[15]
J. Long, Y. Zhang, X. Huang, J. Ren, P. Zhong, B. Wang.
A review of drug therapy in vestibular schwannoma.
Drug Des Devel Ther., 15 (2021), pp. 75-85
[16]
A.L. Håvik, O. Bruland, E. Myrseth, H. Miletic, M. Aarhus, P.M. Knappskog, et al.
Genetic landscape of sporadic vestibular schwannoma.
J Neurosurg., 128 (2018), pp. 911-922
[17]
G. Cioffi, D.N. Yeboa, M. Kelly, N. Patil, N. Manzoor, K. Greppin, et al.
Epidemiology of vestibular schwannoma in the United States, 2004-2016.
Neurooncol Adv., 2 (2020), pp. vdaa135
[18]
K.V. Sadler, N.L. Bowers, C. Hartley, P.T. Smith, S. Tobi, A.J. Wallace, et al.
Sporadic vestibular schwannoma: A molecular testing summary.
J Med Genet., 58 (2021), pp. 227-233
[19]
J. Halliday, S.A. Rutherford, M.G. McCabe, D.G. Evans.
An update on the diagnosis and treatment of vestibular schwannoma.
Expert Rev Neurother., 18 (2018), pp. 29-39
[20]
V.K. Gupta, A. Thakker, K.K. Gupta.
Vestibular schwannoma: What we know and where we are heading.
Head Neck Pathol., 14 (2020), pp. 1058-1066
[21]
J. Liu, P. Liu, Y. Zuo, X. Xu, H. Liu, R. Du, et al.
Hemifacial spasm as rare clinical presentation of vestibular schwannomas.
World Neurosurg., 116 (2018), pp. e889-e894
[22]
S.H. Lee, B.A. Rhee, S.K. Choi, J.S. Koh, Y.J. Lim.
Cerebellopontine angle tumors causing hemifacial spasm: Types, incidence, and mechanism in nine reported cases and literature review.
Acta Neurochir (Wien)., 152 (2010), pp. 1901-1908
[23]
L. Lassaletta, M. Calvino, J.M. Morales-Puebla, P. Lapunzina, L. Rodriguez-de la Rosa, I. Varela-Nieto, et al.
Biomarkers in vestibular schwannoma-associated hearing loss.
Front Neurol., 10 (2019), pp. 978
[24]
J. Waterval, R. Kania, T. Somers.
EAONO position statement on vestibular schwannoma: Imaging assessment. What are the indications for performing a screening MRI scan for a potential vestibular schwannoma?.
J Int Adv Otol., 14 (2018), pp. 95-99
[25]
A. Javed, M. Okoh, Z. Mughal, F. Javed, K. Gupta.
Incidence of vestibular schwannoma in patients with unilateral tinnitus: A systematic review and meta-analysis.
Otol Neurotol., 44 (2023), pp. 841-847
[26]
R.W. Foley, S. Shirazi, R.M. Maweni, K. Walsh, R. McConn Walsh, M. Javadpour, et al.
Signs and symptoms of acoustic neuroma at initial presentation: An exploratory analysis.
Cureus., 9 (2017), pp. e1846
[27]
J.H. Barnes, N.S. Patel, C.M. Lohse, N.M. Tombers, M.J. Link, M.L. Carlson.
Impact of treatment on vestibular schwannoma-associated symptoms: A prospective study comparing treatment modalities.
Otolaryngol Head Neck Surg., 165 (2021), pp. 458-464
[28]
S. Ojha, P.J. Clamp.
A systematic review of interventions for balance dysfunction in patients with vestibular schwannoma.
Otol Neurotol., 41 (2020), pp. e295-e303
[29]
I. Paldor, A.S. Chen, A.H. Kaye.
Growth rate of vestibular schwannoma.
J Clin Neurosci., 32 (2016), pp. 1-8
[30]
M. Kirchmann, K. Karnov, S. Hansen, T. Dethloff, S.E. Stangerup, P. Caye-Thomasen.
Ten-year follow-up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma.
Neurosurgery., 80 (2017), pp. 49-56
[31]
J.P. Marinelli, K.A. Lees, C.M. Lohse, C.L.W. Driscoll, B.A. Neff, M.J. Link, et al.
Natural history of growing sporadic vestibular schwannomas: An argument for continued observation despite documented growth in select cases.
Otol Neurotol., 41 (2020), pp. e1149-e1153
[32]
R.J. Macielak, N.S. Patel, K.A. Lees, C.M. Lohse, J.P. Marinelli, M.J. Link, et al.
Delayed tumor growth in vestibular schwannoma: An argument for lifelong surveillance.
Otol Neurotol., 40 (2019), pp. 1224-1229
[33]
X. Huang, P. Caye-Thomasen, S.E. Stangerup.
Spontaneous tumour shrinkage in 1261 observed patients with sporadic vestibular schwannoma.
J Laryngol Otol., 127 (2013), pp. 739-743
[34]
Z. Schnurman, A. Nakamura, M.W. McQuinn, J.G. Golfinos, J.T. Roland, D. Kondziolka.
Volumetric growth rates of untreated vestibular schwannomas.
J Neurosurg., (2019), pp. 1-7
[35]
M.L. Carlson, J.T. Jacob, E.B. Habermann, A.E. Glasgow, A. Raghunathan, M.J. Link.
Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
J Neurosurg., 125 (2016), pp. 1120-1129
[36]
J. Li, Q. Wang, M. Zhang, G. Zhang, S. Zhang, X. Hui.
Malignant transformation in vestibular schwannoma: Clinical study with survival analysis.
Front Oncol., 11 (2021), pp. 655260
[37]
A. Belyaev, D. Usachev, V. Shimansky, D. Odamanov, L. Shishkina, M. Ryzhova, et al.
Spontaneous transformation of vestibular schwannoma into malignant peripheral nerve sheath tumor.
Asian J Neurosurg., 13 (2018), pp. 810-813
[38]
M.M. Maducdoc, Y. Ghavami, M.E. Linskey, H.R. Djalilian.
Evaluation of reported malignant transformation of vestibular schwannoma: De novo and after stereotactic radiosurgery or surgery.
Otol Neurotol., 36 (2015), pp. 1301-1308
[39]
L. Beni-Adani, S. Pomeranz, I. Flores, Y. Shoshan, Y. Ginosar, I. Ben-Shachar.
Huge acoustic neurinomas presenting in the late stage of pregnancy. Treatment options and review of literature.
Acta Obstet Gynecol Scand., 80 (2001), pp. 179-184
[40]
K.J. Shah, R.B. Chamoun.
Large vestibular schwannomas presenting during pregnancy: Management strategies.
J Neurol Surg B Skull Base., 75 (2014), pp. 214-220
[41]
J.C. Artz, F.C. Timmer, J.J. Mulder, C.W. Cremers, K. Graamans.
Predictors of future growth of sporadic vestibular schwannomas obtained by history and radiologic assessment of the tumor.
Eur Arch Otorhinolaryngol., 266 (2009), pp. 641-646
[42]
C. Strasilla, V. Sychra.
[Imaging-based diagnosis of vestibular schwannoma] German.
[43]
D.H. Kim, S. Lee, S.H. Hwang.
Non-contrast magnetic resonance imaging for diagnosis and monitoring of vestibular schwannomas: A systematic review and meta-analysis.
Otol Neurotol., 40 (2019), pp. 1126-1133
[44]
D.J. Annesley-Williams, R.D. Laitt, J.P. Jenkins, R.T. Ramsden, J.E. Gillespie.
Magnetic resonance imaging in the investigation of sensorineural hearing loss: Is contrast enhancement still necessary?.
J Laryngol Otol., 115 (2001), pp. 14-21
[45]
I.F. Dunn, W.L. Bi, S. Mukundan, B.N. Delman, J. Parish, T. Atkins, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on the role of imaging in the diagnosis and management of patients with vestibular schwannomas.
Neurosurgery., 82 (2018), pp. E32-E34
[46]
T. Bäuerle, M. Saake, M. Uder.
Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention.
Rofo., 193 (2021), pp. 1010-1018
[47]
J.D. Schlaudecker, C.R. Bernheisel.
Gadolinium-associated nephrogenic systemic fibrosis.
Am Fam Physician., 80 (2009), pp. 711-714
[48]
K. Kitajima, T. Maeda, S. Watanabe, Y. Ueno, K. Sugimura.
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Int J Urol., 19 (2012), pp. 806-811
[49]
M. Rogosnitzky, S. Branch.
Gadolinium-based contrast agent toxicity: A review of known and proposed mechanisms.
Biometals., 29 (2016), pp. 365-376
[50]
E.K. Bhargava, P. Coyle, B. Wong, A. Masood, A. Qayyum.
To scan or not to scan-A cross-sectional analysis of the clinical efficacy and cost-effectiveness of audiometric protocols for magnetic resonance imaging screening of vestibular schwannomas.
Otol Neurotol., 40 (2019), pp. S59-S66
[51]
I. Saliba, G. Martineau, M. Chagnon.
Asymmetric hearing loss: Rule 3,000 for screening vestibular schwannoma.
Otol Neurotol., 30 (2009), pp. 515-521
[52]
A.D. Sweeney, M.L. Carlson, N.T. Shepard, D.J. McCracken, E.X. Vivas, B.A. Neff, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on otologic and audiologic screening for patients with vestibular schwannomas.
Neurosurgery., 82 (2018), pp. E29-E31
[53]
K.J. Choi, M.B. Sajisevi, R.R. Kahmke, D.M. Kaylie.
Incidence of retrocochlear pathology found on MRI in patients with non-pulsatile tinnitus.
Otol Neurotol., 36 (2015), pp. 1730-1734
[54]
S. Basu, R. Youngs, A. Mitchell-Innes.
Screening for vestibular schwannoma in the context of an ageing population.
J Laryngol Otol., 133 (2019), pp. 640-649
[55]
D. Borsetto, J. Gair, O. Kenyon, T. Das, N. Donnelly, P. Axon, et al.
When should we stop scanning older patients with vestibular schwannomas?.
J Neurol Surg B Skull Base., 80 (2019), pp. 333-337
[56]
J. Gómez, F. López, M. Arístegui.
Tumores poco frecuentes del APC.
Tumores de oído y de ángulo ponto-cerebeloso, pp. 173-177
[57]
D.J. Totten, N.F. Manzoor, E.L. Perkins, R.F. Labadie, M.L. Bennett, D.S. Haynes.
Cerebellopontine angle and internal auditory canal lipomas: Case series and systematic review.
Laryngoscope., 131 (2021), pp. 2081-2087
[58]
D.R. Friedmann, B. Grobelny, J.G. Golfinos, J.T. Roland Jr..
Nonschwannoma tumors of the cerebellopontine angle.
Otolaryngol Clin North Am., 48 (2015), pp. 461-475
[59]
J. Kanzaki, M. Tos, M. Sanna, D.A. Moffat, E.M. Monsell, K.I. Berliner.
New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma.
Otol Neurotol., 24 (2003), pp. 642-648
[60]
W.T. Koos, J.D. Day, C. Matula, D.I. Levy.
Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas.
J Neurosurg., 88 (1998), pp. 506-512
[61]
L. Lassaletta, J. Gavilán.
[An update on the treatment of vestibular schwannoma] Spanish.
Acta Otorrinolaringol Esp., 60 (2009), pp. 131-140
[62]
M.L. Carlson, E.X. Vivas, D.J. McCracken, A.D. Sweeney, B.A. Neff, N.T. Shepard, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on hearing preservation outcomes in patients with sporadic vestibular schwannomas.
Neurosurgery., 82 (2018), pp. E35-E39
[63]
K. Goshtasbi, M. Abouzari, O. Moshtaghi, R. Sahyouni, A. Sajjadi, H.W. Lin, et al.
The changing landscape of vestibular schwannoma diagnosis and management: A cross-sectional study.
Laryngoscope., 130 (2020), pp. 482-486
[64]
M. Neves Cavada, M. Fook-Ho Lee, N.E. Jufas, R.J. Harvey, N.P. Patel.
Intracanalicular vestibular schwannoma: A systematic review and meta-analysis of therapeutics outcomes.
Otol Neurotol., 42 (2021), pp. 351-362
[65]
P.A. Oddon, M. Montava, F. Salburgo, M. Collin, C. Vercasson, J.P. Lavieille.
Conservative treatment of vestibular schwannoma: Growth and Penn Acoustic Neuroma Quality of Life scale in French language.
Acta Otorhinolaryngol Ital., 37 (2017), pp. 320-327
[66]
X.Q. Zhang, T.S. Chen, W. Wang.
Evaluation of vestibular function in diagnosis of vestibular schwannomas.
Curr Med Sci., 41 (2021), pp. 661-666
[67]
D. Starnoni, L. Giammattei, G. Cossu, M.J. Link, P.H. Roche, A.G. Chacko, et al.
Surgical management for large vestibular schwannomas: A systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.
Acta Neurochir (Wien)., 162 (2020), pp. 2595-2617
[68]
M.L. Carlson, M.J. Link, C.L.W. Driscoll, D.S. Haynes, H.A. Billings, C.M. Lohse, et al.
Working toward consensus on sporadic vestibular schwannoma care: A modified Delphi study.
Otol Neurotol., 41 (2020), pp. e1360-e1371
[69]
T. Somers, R. Kania, J. Waterval, T. van Havenbergh.
What is the required frequency of MRI scanning in the wait and scan management?.
J Int Adv Otol., 14 (2018), pp. 85-89
[70]
E. Zanoletti, A. Mazzoni, A. Martini, R.V. Abbritti, R. Albertini, E. Alexandre, et al.
Surgery of the lateral skull base: A 50-year endeavour.
Acta Otorhinolaryngol Ital., 39 (2019), pp. S1-S146
[71]
M.L. Carlson, J.J. van Gompel, R.M. Wiet, N.M. Tombers, A.K. Devaiah, D. Lal, et al.
A cross-sectional survey of the North American Skull Base Society: Current practice patterns of vestibular schwannoma evaluation and management in North America.
J Neurol Surg B Skull Base., 79 (2018), pp. 289-296
[72]
D.E. Brackmann.
Vestibular schwannoma (acoustic neuroma).
Otolaryngol Clin North Am., 45 (2012), pp. xiii-xv
[73]
M. Bennett, D.S. Haynes.
Surgical approaches and complications in the removal of vestibular schwannomas.
Otolaryngol Clin North Am., 40 (2007), pp. 589-609
[74]
S.F. Ansari, C. Terry, A.A. Cohen-Gadol.
Surgery for vestibular schwannomas: A systematic review of complications by approach.
Neurosurg Focus., 33 (2012), pp. E14
[75]
C.G. Hadjipanayis, M.L. Carlson, M.J. Link, T.A. Rayan, J. Parish, T. Atkins, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on surgical resection for the treatment of patients with vestibular schwannomas.
Neurosurgery., 82 (2018), pp. E40-E43
[76]
R.K. Jackler, L.H. Pitts.
Selection of surgical approach to acoustic neuroma.
Otolaryngol Clin North Am., 25 (1992), pp. 361-387
[77]
G. Grinblat, M. Dandinarasaiah, I. Braverman, A. Taibah, D.G. Lisma, M. Sanna.
Large and giant vestibular schwannomas: Overall outcomes and the factors influencing facial nerve function.
Neurosurg Rev., 44 (2021), pp. 2119-2131
[78]
J.T. Jacob, M.L. Carlson, C.L. Driscoll, M.J. Link.
Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma.
Laryngoscope., 126 (2016), pp. 1877-1882
[79]
Z. Chen, S.C. Prasad, F. di Lella, M. Medina, E. Piccirillo, A. Taibah, et al.
The behavior of residual tumors and facial nerve outcomes after incomplete excision of vestibular schwannomas.
J Neurosurg., 120 (2014), pp. 1278-1287
[80]
A. Monfared, C.E. Corrales, P.V. Theodosopoulos, N.H. Blevins, J.S. Oghalai, S.H. Selesnick, et al.
Facial nerve outcome and tumor control rate as a function of degree of resection in treatment of large acoustic neuromas: Preliminary report of the Acoustic Neuroma Subtotal Resection Study (ANSRS).
Neurosurgery., 79 (2016), pp. 194-203
[81]
R.K. Gurgel, P.V. Theodosopoulos, R.K. Jackler.
Subtotal/near-total treatment of vestibular schwannomas.
Curr Opin Otolaryngol Head Neck Surg., 20 (2012), pp. 380-384
[82]
M.S. Schwartz, E. Kari, B.M. Strickland, K. Berliner, D.E. Brackmann, J.W. House, et al.
Evaluation of the increased use of partial resection of large vestibular schwanommas: Facial nerve outcomes and recurrence/regrowth rates.
Otol Neurotol., 34 (2013), pp. 1456-1464
[83]
Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC.
Otolaryngol Head Neck Surg., 113 (1995), pp. 179-180
[84]
E. Zanoletti, A. Mazzoni, D. d’Avella.
Hearing preservation in small acoustic neuroma: Observation or active therapy? Literature review and institutional experience.
Acta Neurochir (Wien)., 161 (2019), pp. 79-83
[85]
T.A. Meyer, P.A. Canty, E.P. Wilkinson, M.R. Hansen, J.T. Rubinstein, B.J. Gantz.
Small acoustic neuromas: Surgical outcomes versus observation or radiation.
Otol Neurotol., 27 (2006), pp. 380-392
[86]
J. Saliba, R.A. Friedman, R.A. Cueva.
Hearing preservation in vestibular schwannoma surgery.
J Neurol Surg B Skull Base., 80 (2019), pp. 149-155
[87]
H. Jia, Y. Nguyen, D. de Seta, B. Hochet, M. Smail, D. Bernardeschi, et al.
Management of sporadic vestibular schwannoma with contralateral nonserviceable hearing.
Laryngoscope., 130 (2020), pp. E407-E415
[88]
T.S. Quist, D.J. Givens, R.K. Gurgel, R. Chamoun, C. Shelton.
Hearing preservation after middle fossa vestibular schwannoma removal: Are the results durable?.
Otolaryngol Head Neck Surg., 152 (2015), pp. 706-711
[89]
E.M. Dowling, N.S. Patel, C.M. Lohse, C.L.W. Driscoll, B.A. Neff, J.J. van Gompel, et al.
Durability of hearing preservation following microsurgical resection of vestibular schwannoma.
Otol Neurotol., 40 (2019), pp. 1363-1372
[90]
J. Kim, I.S. Moon, J.H. Jeong, H.R. Lee, W.S. Lee.
What really decides the facial function of vestibular schwannoma surgery?.
Clin Exp Otorhinolaryngol., 4 (2011), pp. 168-173
[91]
M. Falcioni, P. Fois, A. Taibah, M. Sanna.
Facial nerve function after vestibular schwannoma surgery.
J Neurosurg., 115 (2011), pp. 820-826
[92]
C. Ginzkey, M. Scheich, W. Harnisch, V. Bonn, D. Ehrmann-Müller, W. Shehata-Dieler, et al.
Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach.
Eur Arch Otorhinolaryngol., 270 (2013), pp. 1209-1216
[93]
A. Pardo-Maza, L. Lassaletta, T. González-Otero, J.M. Roda, S. Moraleda, Á. Arbizu, et al.
Evolution of patients with immediate complete facial paralysis secondary to acoustic neuroma surgery.
Ann Otol Rhinol Laryngol., 125 (2016), pp. 495-500
[94]
L.H. Stieglitz, M. Giordano, V. Gerganov, A. Raabe, A. Samii, M. Samii, et al.
Petrous bone pneumatization is a risk factor for cerebrospinal fluid fistula following vestibular schwannoma surgery.
Neurosurgery., 67 (2010), pp. 509-515
[95]
L.H. Stieglitz, K.H. Wrede, A. Gharabaghi, V.M. Gerganov, A. Samii, M. Samii, et al.
Factors affecting postoperative cerebrospinal fluid leaks after retrosigmoidal craniotomy for vestibular schwannomas.
J Neurosurg., 111 (2009), pp. 874-883
[96]
J. Gavilán, B. Hernández, L. Lassaletta, J.M. Roda.
Parálisis facial iatrogénica. El nervio facial en la cirugia otológica, de base de cráneo y de la glándula parótida.
Tratamiento integral de la parálisis facial, 2.ª ed., pp. 99-110
[97]
E.X. Vivas, M.L. Carlson, B.A. Neff, N.T. Shepard, D.J. McCracken, A.D. Sweeney, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on intraoperative cranial nerve monitoring in vestibular schwannoma surgery.
Neurosurgery., 82 (2018), pp. E44-E46
[98]
M. Chovanec, E. Zvěřina, O. Profant, Z. Balogová, J. Kluh, J. Syka, et al.
Does attempt at hearing preservation microsurgery of vestibular schwannoma affect postoperative tinnitus?.
Biomed Res Int., 2015 (2015), pp. 783169
[99]
M. Samii, V.M. Gerganov, A. Samii.
Functional outcome after complete surgical removal of giant vestibular schwannomas.
J Neurosurg., 112 (2010), pp. 860-867
[100]
A. Batuecas-Caletrio, S. Santacruz-Ruiz, A. Muñoz-Herrera, P. Sousa, A. Otero, N. Perez-Fernandez.
Vestibular compensation after vestibular schwannoma surgery: Normalization of the subjective visual vertical and disability.
Acta Otolaryngol., 133 (2013), pp. 475-480
[101]
J.J. Wang, Y.M. Feng, H. Wang, Y.Q. Wu, H.B. Shi, Z.N. Chen, et al.
Changes in tinnitus after vestibular schwannoma surgery.
[102]
L. Trakolis, F.H. Ebner, K. Machetanz, J. Sandritter, M. Tatagiba, G. Naros.
Postoperative tinnitus after vestibular schwannoma surgery depends on preoperative tinnitus and both pre- and postoperative hearing function.
Front Neurol., 9 (2018), pp. 136
[103]
U. Hani, S. Bakhshi, M.S. Shamim.
Steriotactic radiosurgery for vestibular schwannomas.
J Pak Med Assoc., 70 (2020), pp. 939-941
[104]
M.N. Tsao, A. Sahgal, W. Xu, A. de Salles, M. Hayashi, M. Levivier, et al.
Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) practice guideline.
J Radiosurg SBRT., 5 (2017), pp. 5-24
[105]
M.J. Link, C.L. Driscoll, R.L. Foote, B.E. Pollock.
Radiation therapy and radiosurgery for vestibular schwannomas: Indications, techniques, and results.
Otolaryngol Clin North Am., 45 (2012), pp. 353-366
[106]
P.A. Wackym.
Stereotactic radiosurgery, microsurgery, and expectant management of acoustic neuroma: Basis for informed consent.
Otolaryngol Clin North Am., 38 (2005), pp. 653-670
[107]
G.R. Harsh, A.F. Thornton, P.H. Chapman, M.R. Bussiere, J.D. Rabinov, J.S. Loeffler.
Proton beam stereotactic radiosurgery of vestibular schwannomas.
Int J Radiat Oncol Biol Phys., 54 (2002), pp. 35-44
[108]
M.A. Kalogeridi, A. Kougioumtzopoulou, A. Zygogianni, V. Kouloulias.
Stereotactic radiosurgery and radiotherapy for acoustic neuromas.
Neurosurg Rev., 43 (2020), pp. 941-949
[109]
I. Yang, D. Aranda, S.J. Han, S. Chennupati, M.E. Sughrue, S.W. Cheung, et al.
Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: A systematic review.
J Clin Neurosci., 16 (2009), pp. 742-747
[110]
C.J. Barnes, D.A. Bush, R.I. Grove, L.N. Loredo, J.D. Slater.
Fractionated proton beam therapy for acoustic neuromas: Tumor control and hearing preservation.
Int J Part Ther., 4 (2018), pp. 28-36
[111]
A.R. Savardekar, D. Terrell, S.J. Lele, R. Diaz, P.R. Keesari, K. Trosclair, et al.
Primary treatment of small to medium (<3cm) sporadic vestibular schwannomas: A systematic review and meta-analysis on hearing preservation and tumor control rates for microsurgery versus radiosurgery.
World Neurosurg., 160 (2022), pp. 102-113.e12
[112]
J. Régis, R. Carron, C. Delsanti, D. Porcheron, J.M. Thomassin, X. Murracciole, et al.
Radiosurgery for vestibular schwannomas.
Neurosurg Clin N Am., 24 (2013), pp. 521-530
[113]
A.R. Coughlin, T.J. Willman, S.P. Gubbels.
Systematic review of hearing preservation after radiotherapy for vestibular schwannoma.
Otol Neurotol., 39 (2018), pp. 273-283
[114]
N. Boari, M. Bailo, F. Gagliardi, A. Franzin, M. Gemma, A. del Vecchio, et al.
Gamma Knife radiosurgery for vestibular schwannoma: Clinical results at long-term follow-up in a series of 379 patients.
J Neurosurg., 121 (2014), pp. 123-142
[115]
F.C. Timmer, P.E. Hanssens, A.E. van Haren, J.J. Mulder, C.W. Cremers, A.J. Beynon, et al.
Gamma knife radiosurgery for vestibular schwannomas: Results of hearing preservation in relation to the cochlear radiation dose.
Laryngoscope., 119 (2009), pp. 1076-1081
[116]
D. Rueß, L. Pöhlmann, S. Grau, C. Hamisch, M. Hoevels, H. Treuer, et al.
Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system.
[117]
D.K. Lerner, D. Lee, J.G. Naples, J.A. Brant, D. Bigelow, M. Alonso-Basanta, et al.
Factors associated with facial nerve paresis following Gamma Knife for vestibular schwannoma.
Otol Neurotol., 41 (2020), pp. e83-e88
[118]
J.J. Van Gompel, S. Agazzi, M.L. Carlson, D.A. Adewumi, C.G. Hadjipanayis, J.H. Uhm, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on emerging therapies for the treatment of patients with vestibular schwannomas.
Neurosurgery., 82 (2018), pp. E52-E54
[119]
D. Nasi, E. Zunarelli, A. Puzzolante, E. Moriconi, G. Pavesi.
Early life-threating enlargement of a vestibular schwannoma after gamma knife radiosurgery.
Acta Neurochir (Wien)., 162 (2020), pp. 1977-1982
[120]
C. Seferis, M. Torrens, C. Paraskevopoulou, G. Psichidis.
Malignant transformation in vestibular schwannoma: Report of a single case, literature search, and debate.
J Neurosurg., 121 (2014), pp. 160-166
[121]
L. Troude, M. Boucekine, M. Montava, J.P. Lavieille, J.M. Régis, P.H. Roche.
Adjunctive gamma knife surgery or wait and scan policy after optimal resection of large vestibular schwannomas: Clinical and radiologic outcomes.
World Neurosurg., 118 (2018), pp. e895-e905
[122]
Y. Iwai, K. Ishibashi, Y. Watanabe, G. Uemura, K. Yamanaka.
Functional preservation after planned partial resection followed by gamma knife radiosurgery for large vestibular schwannomas.
World Neurosurg., 84 (2015), pp. 292-300
[123]
V. Kaul, M.K. Cosetti.
Management of vestibular schwannoma (including NF2): Facial nerve considerations.
Otolaryngol Clin North Am., 51 (2018), pp. 1193-1212
[124]
W.G. Cahan, H.Q. Woodard, N.L. Higinbotham, F.W. Stewart, B.L. Coley.
Sarcoma arising in irradiated bone: Report of 11 cases.
[125]
A. Wolf, K. Naylor, M. Tam, A. Habibi, J. Novotny, R. Liščák, et al.
Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: A retrospective, multicentre, cohort study.
Lancet Oncol., 20 (2019), pp. 159-164
[126]
E.A. Nicolli, M. Ruckenstein.
What is the risk of malignant transformation of vestibular schwannoma following radiosurgery?.
Laryngoscope., 125 (2015), pp. 1761-1762
[127]
I.M. Germano, J. Sheehan, J. Parish, T. Atkins, A. Asher, C.G. Hadjipanayis, et al.
Congress of neurological surgeons systematic review and evidence-based guidelines on the role of radiosurgery and radiation therapy in the management of patients with vestibular schwannomas.
Neurosurgery., 82 (2018), pp. E49-E51
[128]
J.M. Frischer, E. Gruber, V. Schöffmann, A. Ertl, R. Höftberger, A. Mallouhi, et al.
Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: A single-center study.
J Neurosurg., (2018), pp. 1-10
[129]
J. Malone, D. Tiberi, J. Sinclair, E. Gaviolli, S. Malone.
Delayed pseudoprogression of a vestibular schwannoma postradiosurgery.
Radiol Case Rep., 15 (2020), pp. 749-752
[130]
S.T. Husseini, E. Piccirillo, A. Taibah, T. Almutair, G. Sequino, M. Sanna.
Salvage surgery of vestibular schwannoma after failed radiotherapy: The Gruppo Otologico experience and review of the literature.
Am J Otolaryngol., 34 (2013), pp. 107-114
[131]
N.S. Patel, M.L. Carlson, M.J. Link, B.A. Neff, J.J. van Gompel, C.L.W. Driscoll.
Cochlear implantation after radiosurgery for vestibular schwannoma.
J Neurosurg., 135 (2021), pp. 126-135
[132]
L. Lassaletta, M. Aristegui, M. Medina, G. Aranguez, R.M. Pérez-Mora, M. Falcioni, et al.
Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.
Eur Arch Otorhinolaryngol., 273 (2016), pp. 27-35
[133]
R.S. Bukoski, E.N. Appelbaum, D.H. Coelho.
Postoperative MRI surveillance of vestibular schwannomas: Is there a standard of care?.
Otol Neurotol., 41 (2020), pp. 265-270
[134]
M.L. Bennett, C.G. Jackson, R. Kaufmann, F. Warren.
Postoperative imaging of vestibular schwannomas.
Otolaryngol Head Neck Surg., 138 (2008), pp. 667-671
[135]
Y. Tomita, M. Tosaka, M. Aihara, K. Horiguchi, Y. Yoshimoto.
Growth of primary and remnant vestibular schwannomas: A three-year follow-up study.
World Neurosurg., 83 (2015), pp. 937-944
[136]
D. Brors, M. Schäfers, D. Bodmer, W. Draf, G. Kahle, B. Schick.
Postoperative magnetic resonance imaging findings after transtemporal and translabyrinthine vestibular schwannoma resection.
Laryngoscope., 113 (2003), pp. 420-426
[137]
M. Fieux, S. Zaouche, S. Rabaste, B. Riche, D. Maucort-Boulch, S. Tringali.
MRI monitoring of residual vestibular schwannomas: Modeling and predictors of growth.
Otol Neurotol., 41 (2020), pp. 1131-1139
[138]
N. Kamal, R.K. Reddy, G. Kohli, H.J. Lee, Y.M. Ying, R.W. Jyung, et al.
The role of Fast Imaging Employing Steady-State Acquisition (FIESTA) magnetic resonance imaging for assessment of delayed enhancement of fat graft packing on postoperative imaging after vestibular schwannoma surgery.
World Neurosurg., 114 (2018), pp. e1066-e1072
[139]
M.L. Carlson, K.M. van Abel, C.L. Driscoll, B.A. Neff, C.W. Beatty, J.I. Lane, et al.
Magnetic resonance imaging surveillance following vestibular schwannoma resection.
Laryngoscope., 122 (2012), pp. 378-388
asdasdasd
Opciones de artículo
Herramientas
Material suplementario